CIK 0001674930
- Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812621304
- Phone
- +1 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-01 | Xie Jian Chief Operating Officer | Shares withheld for taxes | −504 | $32.53 | $16K | 450,791 |
| 2020-09-15 | Gao Hanlin Chief Scientific Officer | Other disposition | −467,659 | 813,692 | ||
| 2020-09-11 | Xie Jian Chief Operating Officer | Other disposition | −150,000 | 451,736 | ||
| 2020-09-02 | KIM PAUL CFO and Treasurer | Sale | −425 | $28.32 | $12K | 335,899 |
| 2020-08-28 | Xie Jian Chief Operating Officer | Sale | −441 | $30.82 | $14K | 601,295 |
| 2020-08-19 | KIM PAUL CFO and Treasurer | Sale | −25,407 | $44.16 | $1.1M | 335,774 |
| 2020-08-17 | KIM PAUL CFO and Treasurer | Sale | −1,308 | $41.11 | $54K | 471,109 |
| 2020-08-17 | KIM PAUL CFO and Treasurer | Sale | −100,000 | $41.47 | $4.1M | 371,109 |
| 2020-08-17 | KIM PAUL CFO and Treasurer | Sale | −9,928 | $43.55 | $432K | 361,181 |
| 2020-08-17 | Gao Hanlin Chief Scientific Officer | Sale | −1,308 | $41.11 | $54K | 1,281,351 |
| 2020-08-17 | BOLGER JOHN C Director | Exercise or conversion | +2,631 | $12.31 | $32K | 5,927 |
| 2020-08-17 | BOLGER JOHN C Director | Sale | −3,914 | $40.87 | $160K | 2,013 |
| 2020-08-17 | BOLGER JOHN C Director | Exercise or conversion · Stock Options (Right to Buy) | −2,631 | 0 | ||
| 2020-08-11 | KIM PAUL CFO and Treasurer | Sale | −1,396 | $42.06 | $59K | 472,417 |
| 2020-08-03 | Xie Jian Chief Operating Officer | Grant or award | +200,000 | 603,712 | ||
| 2020-08-03 | Xie Jian Chief Operating Officer | Sale | −1,976 | $27.86 | $55K | 601,736 |
| 2020-08-03 | KIM PAUL CFO and Treasurer | Grant or award | +40,000 | 473,813 | ||
| 2020-06-02 | KIM PAUL CFO and Treasurer | Sale | −425 | $18.06 | $8K | 433,813 |
| 2020-05-27 | Marsh Linda Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2020-05-27 | Yen Yun Director | Other disposition | −526,315 | 0 |
Page 26 of 31 · 601 trades